Polymyxin B-Injeel

Polymyxin B-Injeel
D 10, D 30, D 200 0.367 ml each.

The polymyxins consist of various, largely similar basic cyclic polypeptides obtained from Bacillus polymyxa, the antibiotic activity of which is directed in particular against Gram-negative micro-organisms. The side effects of Polymyxin B are the same as for colistin (cf. Red List under P 115), i.e. kidney damage, neurotoxic clinical pictures such as paresthesia, vertigo, visual and speech disorders, myasthenic symptoms; further, skin reactions as well as, in rare cases, deterioration of the blood and respiratory paralysis. Serious cardiogenic and nephrogenic secretory disorders apply in general as restrictions of the administration of polymyxins. Polymyxin B (parenterally and in tablet form) is given perorally especially for dyspepsia coli and parenterally for infections caused by Gram-negative micro-organisms, particularly bacterium pyocyaneum, coli and coliform bacteria.

Indications

According to the homoeopathic reversal effect, for neural damage, blood deterioration, as well as symptoms and clinical pictures arising from neurotoxins, as indicated above, and especially when these conditions are associated causally with earlier polymyxin or colistin therapy or therapy with other antibiotics.